Celadon Pharmaceuticals Plc announced that, following the signing of an introductory sales contract with a long-established American business, it has successfully shipped two different medical cannabis products to the United States, representing the Company's first international commercial supply. The American business is a supplier to a number of different US Government departments, and this initial sale has the potential to grow into a material source of additional revenue. The product has been supplied from the Company's UK facility.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75 GBX | 0.00% |
|
-5.06% | -34.78% |
May. 23 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
May. 23 | Celadon Pharmaceuticals plc Announces Supply of Products to New US Customer | CI |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-34.78% | 63.17M | |
+57.01% | 809B | |
+39.52% | 624B | |
-7.09% | 351B | |
+7.40% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.77% | 166B | |
-2.62% | 157B |
- Stock Market
- Equities
- CEL Stock
- News Celadon Pharmaceuticals Plc
- Celadon Pharmaceuticals plc Announces Supply of Products to New US Customer